Publications by authors named "Seth M Pollack"

Claim this Profile
T
The Immune Landscape of Canine Soft Tissue Sarcomas as a Model for Human Soft Tissue Sarcomas.
Regina Hayburn, Dongjun Chung, Arkobato Gupta, Shane Sills, Jennifer Donglan Wu, Seth M Pollack

Cancers (Basel)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Undifferentiated Small Round Cell Sarcomas of Bone and Soft Tissue With EWSR1/FUS::NFATC2 Fusions.
Lawrence J Jennings, Laura M Warmke, Michael Volek, Drew Duckett, Ritu Nayar, Seth M Pollack

Arch Pathol Lab Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Future Directions and Priorities for Cellular Therapy in Sarcoma: A Report from the Strategic Advances in Sarcoma Science Cell Therapy Breakout.
Jacqueline Oliva-Ramirez, David Milewski, Lauren Banks, Kelly M Bailey, Everett J Moding, Seth M Pollack

Cancers (Basel)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
County-level socioeconomic, race-ethnicity, household, and infrastructure vulnerability associations with bone cancer treatment and prognosis in the US.
David J Fei-Zhang, Erik B Gerlach, Shyam Chandrasekar, Mark A Plantz, Nicholas C Arpey, Seth M Pollack

Ann Epidemiol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trends and outcomes for patients receiving neoadjuvant therapy for stage I to III gastric gastrointestinal stromal tumors.
Cade F Bennett, Lauren M Janczewski, Dominic Vitello, Amy Wells, Farres Obeidin, Seth M Pollack

J Gastrointest Surg· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DNA demethylating agents suppress preclinical models of synovial sarcoma.
Nobuhiko Hasegawa, Nezha S Benabdallah, Kyllie Smith-Fry, Li Li, Sarah McCollum, Seth M Pollack

J Clin Invest· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of HLA restriction on racial and ethnic disparities in access to immune therapies for advanced synovial sarcoma.
Vinayak Venkataraman, Hannah R Abrams, David S Shulman, Elizabeth T Loggers, Seth M Pollack

Oncologist· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary Management of Localized Gastrointestinal Stromal Tumors With Imatinib Monotherapy: An Alternative to Resection of Patients Precluded From Surgery.
John S Wang, Brandon L Ellsworth, Rusul Al-Marayaty, Sean Stencel, Farres Obeidin, Seth M Pollack

Clin Med Insights Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of Mitotic Activity and the Size of Any Dedifferentiated Component for Risk Assessment in MDM2-Amplified Liposarcoma.
Hao Wu, Madina Sukhanova, Haiming Tang, Xinyan Lu, Minghao Zhong, Seth M Pollack

Arch Pathol Lab Med· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Melanoma-associated antigen A4: A cancer/testis antigen as a target for adoptive T-cell receptor T-cell therapy.
Gabrielle Knafler, Alan L Ho, Kathleen N Moore, Seth M Pollack, Jean-Marc Navenot

Cancer Treat Rev· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Durable response to treatment of an atypical desmoplastic small round cell tumor with enfortumab-vedotin.
John S Wang, Jack C Shapiro, Sarah Orlando, Rusul Al-Marayaty, Farres Obeidin, Seth M Pollack

J Cancer Res Clin Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paradoxical Response to Neoadjuvant Therapy in Undifferentiated Pleomorphic Sarcoma: Increased Tumor Size on MRI Associated with Favorable Pathology.
Mariam H Goreish, Nicolò Gennaro, Laetitia Perronne, Gorkem Durak, Amir A Borhani, Seth M Pollack

Cancers (Basel)· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Generation of effective and specific human TCRs against tumor/testis antigen NY-ESO-1 in mice with humanized T cell recognition system.
Xiaojing Tina Chen, Matthias Leisegang, Ioannis Gavvovidis, Seth M Pollack, Felix K M Lorenz

Front Immunol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Durable disease regression with copanlisib treatment in PI3K-mutated metastasizing ameloblastoma: A case report.
Meghan M Lynch, Pedro Hermida-Viveiros, Sean Stencel, Hannah Knott, Rusul Al-Maryati, Seth M Pollack

Rare Tumors· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
B7-H3 is widely expressed in soft tissue sarcomas.
Meghan M Lynch, Rusul Al-Marayaty, Farres Obeidin, Borislav A Alexiev, Eleanor Y Chen, Seth M Pollack

BMC Cancer· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Local Immunoradiotherapy in Patients With Metastatic Soft-Tissue Sarcoma-Reply.
Yongwoo David Seo, Seth M Pollack

JAMA Oncol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy and Radiotherapy Combinations for Sarcoma.
Qian S Zhang, John P Hayes, Vinai Gondi, Seth M Pollack

Semin Radiat Oncol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trial.
Sandra P D'Angelo, Dejka M Araujo, Albiruni R Abdul Razak, Mark Agulnik, Steven Attia, Seth M Pollack

Lancet· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early, precise, and safe clinical evaluation of the pharmacodynamic effects of novel agents in the intact human tumor microenvironment.
Kenneth R Gundle, Karthik Rajasekaran, Jeffrey Houlton, Gary B Deutsch, Thomas J Ow, Seth M Pollack

Front Pharmacol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune Assessment Today: Optimizing and Standardizing Efforts to Monitor Immune Responses in Cancer and Beyond.
Surya Pandey, Meghan E Cholak, Rishita Yadali, Jeffrey A Sosman, Marie-Pier Tetreault, Seth M Pollack

Cancers (Basel)· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toll-Like Receptor 4 Agonist Injection With Concurrent Radiotherapy in Patients With Metastatic Soft Tissue Sarcoma: A Phase 1 Nonrandomized Controlled Trial.
Yongwoo David Seo, Hailing Lu, Graeme Black, Kimberly Smythe, Yuexin Yu, Seth M Pollack

JAMA Oncol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pushing forward in sarcoma with a new TCR targeting NY-ESO-1.
Rusul Al-Marayaty, Seth M Pollack

Cell Rep Med· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bolus versus Continuous Intravenous Delivery of Doxorubicin in Soft-Tissue Sarcomas: Post Hoc Analysis of a Prospective Randomized Trial (SARC021/TH CR-406).
Lee D Cranmer, Yao Lu, Rachel S Heise, Karla V Ballman, Elizabeth T Loggers, Seth M Pollack

Clin Cancer Res· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Case Study of Chimeric Antigen Receptor T Cell Function: Donor Therapeutic Differences in Activity and Modulation with Verteporfin.
Jiyong Liang, Dexing Fang, Joy Gumin, Hinda Najem, Moloud Sooreshjani, Seth M Pollack

Cancers (Basel)· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combinations of Chemotherapy and PD-1/PD-L1 Inhibitors in Sarcoma.
Meghan M Lynch, Borislav A Alexiev, Brett A Schroeder, Seth M Pollack

Curr Treat Options Oncol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis